ConductScience.org, home

Paper31887811

Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.

Tobari M and 1 other. Gut Liver, 2020. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. Papers, record 31887811. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31887811

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.
PubMed
Journal
Gut Liver
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.59
iCite
Revised in PubMed
2024-08-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tobari MMakihttps://orcid.org/0000-0002-5900-911X
2Hashimoto EEtsukohttps://orcid.org/0000-0002-0538-1709

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Non-alcoholic Fatty Liver DiseaseMajor topic
Body Mass Index
Female
Humans
Japan
Liver
Male
Obesity
Prevalence
Risk Factors

Source PubMed

Download CSV of topics

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121145841Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.J Hepatol2011https://conductscience.org/library/papers/21145841PubMed
230058778Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers.Hepatol Res2018https://conductscience.org/library/papers/30058778PubMed
318081233Prevalence of fatty liver disease and its risk factors in the population of South China.World J Gastroenterol2007https://conductscience.org/library/papers/18081233PubMed
427599824Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.J Hepatol2017https://conductscience.org/library/papers/27599824PubMed
52643548The effect of age upon liver volume and apparent liver blood flow in healthy man.Hepatology1989https://conductscience.org/library/papers/2643548PubMed
610833486Liver fibrosis in overweight patients.Gastroenterology2000https://conductscience.org/library/papers/10833486PubMed
728670712Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.J Gastroenterol Hepatol2018https://conductscience.org/library/papers/28670712PubMed
830991959Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.BMC Gastroenterol2019https://conductscience.org/library/papers/30991959PubMed
923994581Estrogen: a master regulator of bioenergetic systems in the brain and body.Front Neuroendocrinol2014https://conductscience.org/library/papers/23994581PubMed
1014726171Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.Lancet2004https://conductscience.org/library/papers/14726171PubMed
1125125077Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.Hepatology2015https://conductscience.org/library/papers/25125077PubMed
1222328022Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.J Gastroenterol2012https://conductscience.org/library/papers/22328022PubMed
1316522283Metabolic syndrome in the elderly.Curr Diab Rep2006https://conductscience.org/library/papers/16522283PubMed
1416287793The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.Ann Intern Med2005https://conductscience.org/library/papers/16287793PubMed
1531068503High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men.Endocr J2019https://conductscience.org/library/papers/31068503PubMed
1619670076Final results of a long-term, clinical follow-up in fatty liver patients.Scand J Gastroenterol2009https://conductscience.org/library/papers/19670076PubMed
1725003744Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China.Eur J Gastroenterol Hepatol2014https://conductscience.org/library/papers/25003744PubMed
1817610504Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis.Hepatol Res2007https://conductscience.org/library/papers/17610504PubMed
1916817817Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial.Clin Endocrinol (Oxf)2006https://conductscience.org/library/papers/16817817PubMed
2017498218What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?J Gastroenterol Hepatol2007https://conductscience.org/library/papers/17498218PubMed

See all 102 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42399578Prevalence and associated factors of metabolic dysfunction-associated steatotic liver disease in Taiwan, 2001-2021.Hepatol Int2026https://conductscience.org/library/papers/42399578PubMed
42116409Identifying the association between hemoglobin levels and metabolic dysfunction-associated steatotic liver disease: An observational study and Mendelian randomization analysis.Medicine (Baltimore)2026https://conductscience.org/library/papers/42116409PubMed
41574293Determinants of abnormal liver-related biomarkers in adult COVID-19 patients.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41574293PubMed
41455979The importance of sex dimorphism in liver metabolism and progressive liver diseases.Biol Sex Differ2025https://conductscience.org/library/papers/41455979PubMed
41087942Association of cardiometabolic index with non-alcoholic fatty liver disease among Iranian adults of the amol cohort study.BMC Gastroenterol2025https://conductscience.org/library/papers/41087942PubMed
40336965The relationship between dietary sodium intake and all-cause mortality in patients with non-alcoholic fatty liver disease: a cohort study from NHANES 2003-2018.Front Nutr2025https://conductscience.org/library/papers/40336965PubMed
40299427MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.Biomedicines2025https://conductscience.org/library/papers/40299427PubMed
40001266Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China.Eur J Med Res2025https://conductscience.org/library/papers/40001266PubMed
39846638Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD.Pathophysiology2025https://conductscience.org/library/papers/39846638PubMed
39619223Clinical Characteristics, Risk Factors, and Predictors of Nonobese Fatty Liver Disease: A Cross-Sectional Study.Diabetes Metab Syndr Obes2024https://conductscience.org/library/papers/39619223PubMed
39599633Body Composition in Cases with Normal Alanine Aminotransferase Values in Medical Health Checkups.Nutrients2024https://conductscience.org/library/papers/39599633PubMed
39334354The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective.Lipids Health Dis2024https://conductscience.org/library/papers/39334354PubMed
39108890Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis.Heliyon2024https://conductscience.org/library/papers/39108890PubMed
38577539Update in lean metabolic dysfunction-associated steatotic liver disease.World J Hepatol2024https://conductscience.org/library/papers/38577539PubMed
38162856HbA1c of 5.8% or higher as the most useful indicator for recommendation of ultrasonography to detect nonalcoholic fatty liver disease.JGH Open2023https://conductscience.org/library/papers/38162856PubMed
37901792Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals.Front Aging Neurosci2023https://conductscience.org/library/papers/37901792PubMed
37607790Clinical characteristics in patients with non-alcoholic steatohepatitis in Japan: a case-control study using a 5-year large-scale claims database.BMJ Open2023https://conductscience.org/library/papers/37607790PubMed
37559192Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study.Intest Res2023https://conductscience.org/library/papers/37559192PubMed
37484966A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37484966PubMed
37396181Uncoupling hepatic insulin resistance - hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37396181PubMed

See all 35 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
PNPLA380339PubTator's text mininghttps://conductscience.org/library/genes/80339NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31887811

GET https://conductscience.org/api/papers/v1/31887811/references?page=2